AI in Neuroimaging: Early Disease Detection & Treatment Monitoring | Neuro AI Panel at RSNA 2024 скачать в хорошем качестве

AI in Neuroimaging: Early Disease Detection & Treatment Monitoring | Neuro AI Panel at RSNA 2024

🚀 The Neuro AI Panel by CARPL.ai at RSNA'24 explored how AI is enhancing neuroimaging, from early disease detection to treatment monitoring. Moderated by Sarang Ingole, MD, Medical Director at CARPL.ai, and an experienced diagnostic and interventional radiologist, the panel featured Fabio García Castro, Quibim, and YoungJoon Moon, Neurophet. Here is a snapshot of the key discussion points 👇 • AI-driven brain imaging enables early detection of neurodegenerative diseases by analyzing brain volumetrics and white matter changes. • Advanced tools help identify amyloid-related imaging abnormalities (ARIA), crucial for monitoring Alzheimer’s treatments and assessing potential risks. • Quantitative imaging provides radiologists and neurologists with objective biomarkers, improving diagnostic accuracy and treatment planning. • Seamless integration into clinical workflows ensures accessibility across hospitals and research centers, with cloud and on-premise deployment options.